Net profit of Vaishali Pharma rose 6.92% to Rs 1.70 crore in the quarter ended June 2024 as against Rs 1.59 crore during the previous quarter ended June 2023. Sales rose 34.72% to Rs 18.08 crore in the quarter ended June 2024 as against Rs 13.42 crore during the previous quarter ended June 2023.
Particulars | Quarter Ended |
| Jun. 2024 | Jun. 2023 | % Var. |
Sales | 18.08 | 13.42 | 35 |
OPM % | 13.00 | 17.21 | - |
PBDT | 2.39 | 2.24 | 7 |
PBT | 2.27 | 2.12 | 7 |
NP | 1.70 | 1.59 | 7 |